Oppenheimer & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,836
Closed -$561K 1597
2024
Q4
$561K Buy
+16,836
New +$546K 0.01% 1028
2024
Q3
Sell
-13,400
Closed -$301K 1530
2024
Q2
$301K Buy
+13,400
New +$297K ﹤0.01% 1188
2021
Q2
Sell
-9,027
Closed -$204K 1528
2021
Q1
$204K Buy
+9,027
New +$204K ﹤0.01% 1345
2020
Q2
Sell
-27,550
Closed -$474K 1282
2020
Q1
$474K Buy
27,550
+14,715
+115% +$269K 0.01% 744
2019
Q4
$226K Sell
12,835
-10,774
-46% -$183K 0.01% 1135
2019
Q3
$417K Sell
23,609
-3,176
-12% -$64.3K 0.01% 864
2019
Q2
$572K Sell
26,785
-7,528
-22% -$158K 0.02% 761
2019
Q1
$816K Buy
34,313
+11,563
+51% +$264K 0.02% 642
2018
Q4
$447K Buy
22,750
+2,269
+11% +$40.5K 0.01% 775
2018
Q3
$363K Sell
20,481
-8,652
-30% -$169K 0.01% 994
2018
Q2
$627K Buy
29,133
+10,997
+61% +$227K 0.02% 771
2018
Q1
$402K Sell
18,136
-4,610
-20% -$127K 0.01% 935
2017
Q4
$691K Buy
+22,746
New +$605K 0.02% 743
2017
Q3
Sell
-14,128
Closed -$348K 1321
2017
Q2
$348K Buy
14,128
+2,129
+18% +$45K 0.01% 969
2017
Q1
$260K Buy
+11,999
New +$244K 0.01% 1054
2015
Q4
Sell
-534,025
Closed -$3M 1306
2015
Q3
$3M Buy
534,025
+292,334
+121% +$1.59M 0.09% 260
2015
Q2
$909K Buy
241,691
+59,121
+32% +$192K 0.03% 658
2015
Q1
$469K Buy
182,570
+77,575
+74% +$180K 0.01% 894
2014
Q4
$151K Buy
104,995
+25,100
+31% +$39.1K ﹤0.01% 1283
2014
Q3
$122K Sell
79,895
-116,800
-59% -$375K ﹤0.01% 1329
2014
Q2
$666K Buy
196,695
+46,924
+31% +$162K 0.02% 760
2014
Q1
$530K Buy
+149,771
New +$1.02M 0.02% 804

Other funds holding EXEL

Oppenheimer & Co's EXEL Position: Q1 2025 in Review

Oppenheimer & Co sold out of Exelixis (EXEL) in Q1 2025, closing a stake of 16,836 shares — an estimated $561K sold.

Oppenheimer & Co first reported a position in EXEL in Q1 2014 and held it in 22 quarters. The position peaked at $3M in Q3 2015. 557 funds tracked by Wall St. Rank hold EXEL as of Q1 2025.

  • Oppenheimer & Co reported no remaining Exelixis position as of Q1 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 16,836 Exelixis shares in Q1 2025, an estimated $561K.
  • Oppenheimer & Co first reported a position in Exelixis in Q1 2014 and held it in 22 quarters.
  • Oppenheimer & Co's Exelixis position peaked at $3M in Q3 2015.
  • 557 funds tracked by Wall St. Rank held Exelixis as of Q1 2025.

Based on Oppenheimer & Co's 13F filing for Q1 2025, filed 23 Apr 2025.